Nektar Therapeutics Statistics
Total Valuation
NKTR has a market cap or net worth of $489.16 million. The enterprise value is $489.98 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NKTR has 19.02 million shares outstanding. The number of shares has increased by 7.17% in one year.
| Current Share Class | 19.02M |
| Shares Outstanding | 19.02M |
| Shares Change (YoY) | +7.17% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 0.91% |
| Owned by Institutions (%) | 48.62% |
| Float | 17.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.81 |
| Forward PS | 11.05 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.61
| Current Ratio | 2.61 |
| Quick Ratio | 2.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.24 |
Financial Efficiency
Return on equity (ROE) is -440.80% and return on invested capital (ROIC) is -38.49%.
| Return on Equity (ROE) | -440.80% |
| Return on Assets (ROA) | -31.57% |
| Return on Invested Capital (ROIC) | -38.49% |
| Return on Capital Employed (ROCE) | -102.19% |
| Revenue Per Employee | $1.23M |
| Profits Per Employee | -$2.00M |
| Employee Count | 61 |
| Asset Turnover | 0.27 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -386,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.47% in the last 52 weeks. The beta is 0.96, so NKTR's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +54.47% |
| 50-Day Moving Average | 20.19 |
| 200-Day Moving Average | 15.03 |
| Relative Strength Index (RSI) | 61.80 |
| Average Volume (20 Days) | 702,199 |
Short Selling Information
The latest short interest is 1.03 million, so 5.40% of the outstanding shares have been sold short.
| Short Interest | 1.03M |
| Short Previous Month | 1.16M |
| Short % of Shares Out | 5.40% |
| Short % of Float | 5.84% |
| Short Ratio (days to cover) | 0.85 |
Income Statement
In the last 12 months, NKTR had revenue of $74.93 million and -$122.27 million in losses. Loss per share was -$8.72.
| Revenue | 74.93M |
| Gross Profit | 62.52M |
| Operating Income | -139.13M |
| Pretax Income | -177.16M |
| Net Income | -122.27M |
| EBITDA | -137.17M |
| EBIT | -139.13M |
| Loss Per Share | -$8.72 |
Full Income StatementBalance Sheet
The company has $175.90 million in cash and $176.73 million in debt, giving a net cash position of -$826,000 or -$0.04 per share.
| Cash & Cash Equivalents | 175.90M |
| Total Debt | 176.73M |
| Net Cash | -826,000 |
| Net Cash Per Share | -$0.04 |
| Equity (Book Value) | -24.21M |
| Book Value Per Share | -1.94 |
| Working Capital | 115.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$184.91 million and capital expenditures -$1.16 million, giving a free cash flow of -$186.07 million.
| Operating Cash Flow | -184.91M |
| Capital Expenditures | -1.16M |
| Free Cash Flow | -186.07M |
| FCF Per Share | -$9.78 |
Full Cash Flow StatementMargins
Gross margin is 83.44%, with operating and profit margins of -185.67% and -163.17%.
| Gross Margin | 83.44% |
| Operating Margin | -185.67% |
| Pretax Margin | -163.69% |
| Profit Margin | -163.17% |
| EBITDA Margin | -183.05% |
| EBIT Margin | -185.67% |
| FCF Margin | n/a |
Dividends & Yields
NKTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.17% |
| Shareholder Yield | -7.17% |
| Earnings Yield | -25.00% |
| FCF Yield | -38.04% |
Analyst Forecast
The average price target for NKTR is $81.67, which is 217.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $81.67 |
| Price Target Difference | 217.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 2.66% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
NKTR has an Altman Z-Score of -25.58 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.58 |
| Piotroski F-Score | 3 |